| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000029427 |
| Receipt No. | R000033622 |
| Official scientific title of the study | Examination into the physical activity level and related factor among post allogeneic hematopoietic cell transplantation patients |
| Date of disclosure of the study information | 2017/10/06 |
| Last modified on | 2017/10/05 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Examination into the physical activity level and related factor among post allogeneic hematopoietic cell transplantation patients | |
| Title of the study (Brief title) | Examination into the physical activity level and related factor among post allo-HCT patients | |
| Region |
|
|
| Condition | ||
| Condition | Hematologic malignancy | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the physical activity level,related factor and the relationship between physical activity level and HRQOL among post allogeneic hematopoietic cell transplantation patients
|
| Basic objectives2 | Others |
| Basic objectives -Others | Relationship between physical activity and HRQOL |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Objective and subjective physical activity level and subjective evaluation of QOL among post allogeneic hematopoietic cell transplantation patients |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patient who gained consent to participate in research
2)Patient aged from 20 to 70 3)Patient who is Within 2 years after allogeneic hematopoietic cell transplantation 4)patient who can understand and write down japanese 5)Patient who is judged by primary doctor |
|||
| Key exclusion criteria | 1)Patient who has Respiratory complications like always needed oxygen inhalation
2)Patient decided by primary doctor that it is not suitable for participating in research because of cognitive/mental disorder 3)Patient with recurrence or secondary cancer 4)Patient who is more than 3 PS(performace status) 5)Patinet who is judged by primary doctor that it is not suitable for participating in research |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Tatsuya Kishi |
| Organization | Keio university Graduate School of Health Management |
| Division name | Nursing |
| Address | 4411 Endo, Fujisawa-shi, Kanagawa |
| TEL | 0466-49-6265 |
| h16707tk@sfc.keio.ac.jp | |
| Public contact | |
| Name of contact person | Tatsuya Kishi |
| Organization | Keio University Graduate School of Health Management |
| Division name | Nursing |
| Address | 4411 Endo, Fujisawa-shi, Kanagawa |
| TEL | 0466-49-6265 |
| Homepage URL | |
| h16707tk@sfc.keio.ac.jp | |
| Sponsor | |
| Institute | Keio University Graduate School of Health Management |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self-sustaining
|
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | National Cancer Center Hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立研究開発法人 国立がん研究センター中央病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Design: Observational cross-sectional study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033622 |